Oregon Health & Science University: Targeted Therapy Stops Rare, Joint-Destroying Tumor
August 22, 2019
August 22, 2019
PORTLAND, Oregon, Aug. 22 [TNSmedicalresearch] -- Oregon Health and Science University issued the following news release:
* * *
- OHSU cancer researcher helped lead study finding first effective drug therapy for tenosynovial giant cell tumor, or TGCT
* * *
Brian Matekovich was in his late 30s when he began experiencing inexplicable pain and swelling in his right knee. It took years to get a correct diagnosis: tenosynovial giant cell tumor, or T . . .
* * *
- OHSU cancer researcher helped lead study finding first effective drug therapy for tenosynovial giant cell tumor, or TGCT
* * *
Brian Matekovich was in his late 30s when he began experiencing inexplicable pain and swelling in his right knee. It took years to get a correct diagnosis: tenosynovial giant cell tumor, or T . . .